Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes

Published:2023-12 Issue: Volume: Page:
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Rajakumaraswamy Nishanthan,Gandhi Mitul,Wei Andrew H.,Sallman David A.,Daver Naval G.,Mo Shuyuan,Iqbal Shahed,Karalliyadda Roshan,Chen Manli,Wang Yunfei^ORCID,Vyas Paresh

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference21 articles.

1. Myelodysplastic syndromes/neoplasms: recent classification system based on World Health Organization classification of tumors—International Agency for Research on Cancer for hematopoietic and lymphoid tissues;Gupta;J Blood Med,2010

2. Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk disease;Mohty;J Hematol Oncol,2022

3. Revised international prognostic scoring system for myelodysplastic syndromes;Greenberg;Blood,2012

4. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies;Wattel;Blood,1994

5. TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis;Kulasekararaj;Br J Haematol,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP